Current Opinion in Gastroenterology was launched in 1985. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of gastroenterology is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce one of the Section Editors for this issue.
Don C. Rockey
Dr Don C. Rockey completed internship, residency, chief residency, and fellowship at the University of California, San Francisco, USA. He is currently Chairman of the Department of Medicine, the Medical University, Charleston, USA. He has active basic and clinical research interests in liver disease. He has worked on areas ranging from clinical management problems in liver diseases such as portal hypertension, hepatic blood flow, drug induced liver injury and complications of chronic liver disease to basic liver cell and molecular biology. The central theme of his laboratory research revolves around understanding the cell and molecular basis of fibrosis and portal hypertension. His laboratory initially demonstrated that a key player, the hepatic stellate cell, exhibits a contractile phenotype. Further, following liver injury, stellate cells exhibit exaggerated contractility, constrict liver sinusoids, and contribute to increased intrahepatic vascular resistance typical of portal hypertension. He and his laboratory have gone on to explore a number of molecular events important in this disease. Dr Rockey has had highly active clinical interests in multiple aspects of chronic liver disease as well as drug induced liver injury. Dr Rockey and his colleagues have published over 150 peer reviewed scientific papers related to his research and over 100 editorials, reviews, and book chapters. He has served in a number of capacities on behalf of major US Gastroenterology and Liver societies including for the American Gastroenterological Association (AGA) and the American Association for the Study of Liver Disease (AASLD). Among many responsibilities, he has served as Chair of The AGA Research Policy Committee, Chair of the AASLD Training and Workforce committee. He has also been active in the Alliance for Academic Internal Medicine (AAIM) having served as President for the Association of Subspecialty Professors (ASP). He has had a number of editorial responsibilities, including as Associate Editor for Hepatology, Associate Editor for Liver International and has served on various NIH and other study sections, and editorial boards.
David S. Sanders
Professor David S. Sanders is a Professor of Gastroenterology and a Consultant Gastroenterologist at the Royal Hallamshire Hospital & the University of Sheffield. He has published >300 peer reviewed papers (H-score 50). He is internationally recognised for his work in coeliac disease, gastrostomy feeding and small bowel endoscopy. His other research interests include pancreatic exocrine insufficiency, irritable bowel syndrome and gastrointestinal bleeding. In 2010 he received a European Rising Star Award and in 2011 a Cuthbertson Medal (UK Nutrition Society). He has been selected to receive the most prestigious award of the Swedish Gastroenterology Society in 2017 (Bengt Ihre Award). His clinical work with patients who have coeliac disease has resulted in him being awarded the Coeliac UK Healthcare Professional of the Year Award (2010) & the inaugural Complete Nutrition Coeliac Health Care Professional Award (2013). He is fortunate to work as part of the Sheffield Gastroenterology Team which has been recognised for their standards of care. The Small Bowel Endoscopy Service won one of the inaugural British Society of Gastroenterology National GI Care awards (2011) & the Medipex award (2013). In 2012 the PEG team won both Health Service Journal primary care and integrated clinical care awards. In 2014 the Hallamshire Gastroenterology team, won one of the SAGE (Shire Awards for Gastrointestinal Excellence) awards for their primary care and GI bleed unit services. Professor Sanders has chaired both the British Society of Gastroenterology (BSG) Small Bowel and Nutrition Section (2006–2012) & the BSG Audit Committee (2010–2013). He is the current Chair of the Coeliac UK Health Advisory Council, BSG Council Member and President of the International Society for the Study of Coeliac Disease (ISSCD). http://www.profdavidsanders.co.uk/.